Galleon Pharmaceuticals

About:

Galleon Pharmaceuticals is engaged in the discovery and development of medicines for breathing-control conditions in the United States.

Website: http://www.galleonpharma.com

Twitter/X: zeesnoring

Top Investors: TPG, BioAdvance, Morgenthaler Ventures, HealthCare Ventures

Description:

Galleon Pharmaceuticals engages in the discovery and development of medicines for breathing-control conditions in the United States. It focuses on developing a portfolio of therapeutics for the treatment of sleep apnea, ventilator weaning, anesthetic/analgesic-induced respiratory depression, COPD, obesity-hypoventilation syndrome, and other common diseases. The company was incorporated in 2003 and is based in Horsham, Pennsylvania.

Total Funding Amount:

$53M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Horsham, Pennsylvania, United States

Founded Date:

2003-01-01

Contact Email:

discovery(AT)galleonpharma.com

Founders:

James C. Mannion

Number of Employees:

11-50

Last Funding Date:

2015-06-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai